Can Spironolactone Cause Amenorrhea?
Yes, spironolactone commonly causes menstrual irregularities including amenorrhea, occurring in 15-30% of patients, with this effect being dose-dependent and generally reversible upon discontinuation.
Mechanism and Incidence
Spironolactone has antagonistic effects on both androgen and progesterone receptors 1. The drug demonstrates progestational activity that can directly affect menstrual function 2. Menstrual irregularities represent the most common side effect of spironolactone therapy, with documented rates of 15-30% across multiple studies 1.
The FDA drug label explicitly lists amenorrhea and irregular menses as adverse effects in the reproductive system category 3. Additionally, the 2016 AAD guidelines specifically document amenorrhea as a recognized adverse effect 4.
Dose-Dependent Relationship
The risk of menstrual irregularities increases substantially with higher doses. Patients receiving 200 mg/day have a relative risk of 4.12 (95% CI 3.27-5.19) compared to those on lower doses 1. This dose-response relationship is critical for clinical decision-making.
Clinical Management Strategy
When amenorrhea occurs with spironolactone:
- Consider concomitant hormonal contraception: Combined oral contraceptives (COCs) or hormonal intrauterine devices can minimize menstrual irregularities 1
- Dose reduction: Lowering the spironolactone dose often resolves menstrual disturbances while maintaining therapeutic benefit
- Reversibility: The amenorrhea is typically reversible upon discontinuation, as documented in case reports of patients with chronic liver disease where amenorrhea resolved when spironolactone was stopped 5
Important Caveats
The 2024 AAD guidelines note that while menstrual irregularities are common (40.6% vs 0% compared to placebo; RR 10.89), these effects are less common among patients using COCs 6. This provides a practical management approach: co-prescribe hormonal contraception when initiating spironolactone in reproductive-age women who desire menstrual regularity.
Animal studies demonstrate that spironolactone at 100 mg/kg/day can inhibit ovulation and prolong the estrous cycle 3, and human studies confirm progestational activity that can delay or inhibit menstruation 2. However, these effects do not appear to cause permanent reproductive dysfunction, as evidenced by normal oocyte yield and maturation rates in patients undergoing controlled ovarian hyperstimulation while on spironolactone 7.
Pregnancy Considerations
While amenorrhea itself is reversible, spironolactone should be avoided in pregnancy due to potential feminization of male fetuses based on animal data 3. The pregnancy category is C, and patients should be counseled about contraception 1.